Pharmacological Reports

简称 PHARMACOL REP ·POLAND ·出版周期 Bimonthly ·年均收录 193 篇

3.8

最新影响因子

5.40%

自引率

较易

投稿难度

平均6.0个月

审稿周期

期刊简介

Pharmacological Reports是一本国际性药理学杂志，ISSN号为1734-1140，由波兰的Springer Nature出版社出版，出版地为波兰，出版周期为双月刊。该杂志的影响因子根据最新数据约为3.0左右，属于非开放获取（非OA）期刊，被SCI收录，在中科院分区中通常位于医学或药理学领域的3区或4区。杂志的发文特点主要集中在药理学、神经药理学、药物代谢、毒理学及相关实验与临床研究领域，尤其关注药物作用机制、新药开发及治疗应用。其质量较为稳定，适合药理学领域的研究者投稿，但需注意其影响因子相对中等，竞争可能不如顶级期刊激烈，投稿时需确保研究内容符合期刊范围以避免拒稿风险。

影响因子趋势

近期发表

Cancer therapy-related cognitive impairment, part 1: an integrative clinical–mechanistic framework from phenotypes to convergent neurobiological pathways 2026-09-17

Is teriparatide linked to osteosarcoma? A disproportionality analysis of the FAERS database 2026-09-17

Tetrahydrocurcumin suppresses FcεRI- and MRGPRX2-mediated mast cell activation and attenuates peanut-induced anaphylaxis in an in vitro and in vivo study 2026-09-14

Drugs associated with retroperitoneal fibrosis: assessment of the 1969–2025 Food and Drug Administration (FDA) pharmacovigilance database 2026-09-11

Cancer therapy-related cognitive impairment, part 2: from bench to bedside—and back: why candidate therapies for cancer therapy-related cognitive impairment fail to translate 2026-09-11

Unveiling novel transcriptomic prognostic biomarkers for specific breast cancer subtypes and treatment regimens 2026-09-09

Gut microbiota as a modulator of HDAC: insights into Alzheimer’s disease treatment 2026-09-09

Interactions of ACEA and WIN 55,212-2 mesylate with temozolomide and cisplatin in neuroblastoma and glioblastoma cell lines: an isobolographic analysis 2026-09-09

Signs of antidepressant-like effects of temozolomide as measured in the forced-swim test in adult rats 2026-09-01

The anti-CEACAM1 agonistic antibody CCM5.01 inhibits the growth of colon cancer cell lines in 2D and 3D models 2026-08-31